Skip to Content
Merck
CN
  • Severe hepatitis induced by cyproterone acetate: role of corticosteroids. A case report.

Severe hepatitis induced by cyproterone acetate: role of corticosteroids. A case report.

Annals of hepatology (2013-01-08)
Ludovico Abenavoli, Natasa Milic, Michel Beaugrand
ABSTRACT

Cyproterone acetate (CPA) is an oral anti-androgen commonly used to treat advanced prostate cancer. A variety of hepatotoxic reactions has been reported with CPA. Here we describe a case of a male patient who developed severe drug-induced hepatotoxicity during the treatment with CPA. The case, presenting sub-acute hepatitis, was characterized by a rapid evolution of cirrhosis and a protracted activity during the period of a few months despite the treatment withdrawal and an apparent benefits of corticosteroids, suggesting their indication in life threatening cases.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Ursodeoxycholic acid, ≥99%
Ursodeoxycholic acid, European Pharmacopoeia (EP) Reference Standard
Ursodeoxycholic acid for system suitability, European Pharmacopoeia (EP) Reference Standard